Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | PEPD | P12955 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | MB | P02144 | 1/20 | 0.47 |
| ▸ | CA3 | P07451 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | RARG | P13631 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2933871 | 0.84 | KMT2A (0.63) | MEN1KMT2AALDH1A1MAPTMAOA | |
| SCHEMBL572726 | 0.84 | GAA (0.56) | KMT2AALDH1A1MAPTCA12CA1 | |
| SCHEMBL1532371 | 0.84 | POLB (0.63) | MEN1KMT2AALDH1A1MAPTCA12 | |
| SCHEMBL11763476 | 0.84 | KMT2A (0.59) | MEN1KMT2AALDH1A1MAPTCA12 | |
| SCHEMBL4835086 | 0.84 | MEN1 (0.65) | MEN1KMT2AALDH1A1MAPTGAA | |
| SCHEMBL733776 | 0.83 | EPHX2 (0.53) | ALDH1A1MAPTCYP3A4TSHRGAA | |
| SCHEMBL28763494 | 0.82 | CYP1A1 (0.59) | CYP1A1MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL7428098 | 0.81 | ALDH1A1 (0.60) | MEN1KMT2AALDH1A1MAPTHTT | |
| SCHEMBL10965290 | 0.81 | MAPT (0.58) | MEN1KMT2AALDH1A1MAPTMAPK1 | |
| SCHEMBL5306821 | 0.80 | SMN1; SMN2 (0.58) | MEN1KMT2AALDH1A1MAPTCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130053598-A1 | METHOD FOR PRODUCING A CROSS-COUPLING PRODUCT OF A BENZENOID DIAZONIUM SALT | ZYLUM BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE II KG (DE) | 2013-02-28 | — | — | US | disclosed |
| CN-102459156-A | Process for preparing cross-coupled products of benzenoid diazonium salts | ZYLUM BETEILIGUNGSGES PAT II | 2012-05-16 | — | — | CN | disclosed |
| EP-2421822-A1 | METHOD FOR PRODUCING A CROSS-COUPLING PRODUCT OF A BENZENOID DIAZONIUM SALT | Zylum Beteiligungsgesellschaft mbH & Co. Patente II KG (DE) | 2012-02-29 | — | — | EP | disclosed |
| WO-2010122105-A1 | METHOD FOR PRODUCING A CROSS-COUPLING PRODUCT OF A BENZENOID DIAZONIUM SALT | ZYLUM BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE II KG (DE) | 2010-10-28 | — | — | WO | disclosed |
| US-3993768-A | FUNGICIDES | SYNTEX (U.S.A.) INC. (US) | 1976-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053598-A1 | METHOD FOR PRODUCING A CROSS-COUPLING PRODUCT OF A BENZENOID DIAZONIUM SALT | CBR3, CBR1, NOX3 | CYP1A1 1883/4885MEN1 1589/4885KMT2A 2189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.